Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01695122Phase 2Completed
Phase 2, open-label, single-arm trial of valproic acid in head and neck squamous cell carcinoma (HNSCC), sponsored by Instituto do Câncer do Estado de São Paulo. Primary endpoint: Response Rate. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01695122.